Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Aung Naing, MD
CONTACT
Lead
M.D. Anderson Cancer Center
With
Primary Objective: To determine the safety and tolerability of NP-101 in patients with solid tumors. Secondary Objective: To determine the preliminary antitumor activity of NP-101. Although the clinical benefit of NP-101 has not yet been established, the intent of offering this treatment is to provide a possible therapeutic benefit and thus, the patient will be carefully monitored for tumor response and symptom relief in addition to safety and tolerability. Exploratory Objectives: To evaluate immune-related markers of response and resistance to NP-101. To bank blood samples for future pharmacokinetic (PK) analyses of NP-101.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted